Molecular epidemiology: What the epidemiologist needs to know

Current Opinion in Infectious Diseases

Volumn 10, Issue 4, 1997, Pages 296-303

  Van Belkum, Alex ^a   Verbrugh, Henri ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; RNA;

BACTERIUM IDENTIFICATION; DNA DETERMINATION; EPIDEMIOLOGY; FUNGUS IDENTIFICATION; HUMAN; INFECTION; MOLECULAR GENETICS; NONHUMAN; REVIEW; RNA ANALYSIS; TAXONOMY; VIRUS TYPING;

EID: 0030757119     PISSN: 09517375     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001432-199708000-00010     Document Type: Review

References (64)

1. Musser JM: Molecular population genetic analysis of emerged bacterial pathogens: selected insights. Emerg Infect Dis 1996, 2:1- 17.
2. Struelens MJ, Bauernfeind A, Van Belkum A, Blanc D, Cookson BD, Dijkshoorn L, El Sohl N, Etienne J, Garaizar J, Gerner-Smidt P et al.: Consensus guidelines for appropriate use and evaluation of microbial epidemiologic typing systems. Clin Microbiol Infect 1996, 2:2-11. In Europe a study group on epidemiology markers (European Study Group on Epidemiological Markers, ESGEM) functions under the auspices of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID). The group focuses on the development of theoretical and practical frameworks for the performance of microbiological typing research. The paper gives a detailed and group-consensus description of the theoretical basis of phenotypic and genotypic analysis of bacterial pathogens. Definitions are given and appropriate guidelines for the evaluation of the quality of novel systems are presented.
3. Tenover F, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B: Interpreting chromosomal DNA restriction patterns produced by PFGE: criteria for bacterial strain typing. J Clin Microbiol 1996, 33:2233-2239. When typing bacterial pathogens by PFGE, the experimental output presents as complicated banding patterns of DNA macro-restriction fragments. These patterns are generally complex and at present there are no standardised and uniform criteria for analyzing these fragment patterns. In this paper guidelines are presented on the basis of a meta analysis of data available in the literature: criteria for interpretation are suggested and a sound basis for further discussions regarding the use of molecular typing methods is laid.
4. Cookson BD, Aparicio P, Deplano A, Struelens M, Goering R, Marples R: Inter centre comparison of PFGE for the typing of methicillin resistant Staphylococcus aureus. J Med Microbiol 1996, 44:179- 184.
5. Val Belkum A, Kluytmans J, Van Leeuwen W, Bax R, Quint W, Peters E, Fluit A, Vandenbroucke-Grauls C, Van den Brule A, Koeleman H et al.: Multicenter evaluation of arbitrarily primed PCR for typing of Staphylococcus aureus strains. J Clin Microbiol 1995, 33:1537- 1547.
6. Maslow J, Mulligan ME: Epidemiologic typing systems. Infect Control Hosp Epidemiol 1996, 17:595-604.
7. Vandamme P, Pot B, Gillis M, De Vos P, Kersters K, Swings J: Polyphasic taxonomy, a consensus approach to bacterial systematics. Microbiol Rev 1996, 60:407-438.
8. Goffeau A, Barrell BG, Bussey H, Davis RW, Dujon B, Feldmann H, Galibert F, Hoheisel JD, Jacq J, Johnston M et al.: Life with 6000 genes. Science 1996, 274:546-567. Through a worldwide collaboration the 12 068 kbp Saccharomyces cerevisiae genome was sequenced, enabling future studies on genome redundancies, gene expression, higher order organization of the chromosomes and genetic variability.
9. Bult CJ, White O, Olsen GJ, Zhou L, Fleischmann RD, Sutton GG, Blake GJ, FitzGerald LM, Clayton RA, Gocayne JD et al.: Complete genome sequence of the methanogenic archaeon, Methanococcus jannaschii. Science 1996, 273:1058-1068. The third bacterial species for which the complete genome sequence reached the public domain. Interesting discussions on the evolutionary position of archaebacteria are ongoing. Many other whole genome sequences are currently in the final stages of determination. Whether these data will ever enter the public domain, however, is subject to matters of commercial concern: the exclusive(?) proprietary rights are currently being debated by public financiers, patent attorneys and company lawyers.
10. Chee M, Yang R, Hubbell E, Berno A, Huang XC, Stern D, Winkler J, Lockhart DJ, Morris MS, Fodor SPA: Accessing genetic information with high density DNA arrays. Science 1996, 274:610-614. Using small DNA chips containing over 135 000 probes complementary to the human mitochondrial genome, in combination with dual labelling systems, complete hybridization patterns were revealed in a matter of minutes. Sequence polymorphisms were detected with single(!) base resolution. General systems as described can be used for analyses in the fields of gene expression, genetic linkage, genetic variability and the typing of infectious agents.
11. Elena SF, Cooper VS, Lenski RE: Punctuated evolution caused by selection of rare beneficial mutations. Science 1996, 272:1802- 1804.
12. Peak IRA, Jennings MP, Hood DW, Bisercic M, Moxon ER: Tetrameric repeat units associated with virulence factor phase variation in Haemophilus also occur in Neisseria spp. and Moraxella catarrhalis. FEMS Microbiol Lett 1996, 137:109-114.
13. Bingen E, Denamur E, Brahimi N, Elion J: Genotyping may provide rapid identification of Escherichia coli K1 organisms that cause neonatal meningitis. Clin Infect Dis 1996, 22:152-156.
14. Collier MC, Stock F, DeGirolami PC, Samore MH, Cartwright CP: Comparison of PCR-based approaches to molecular epidemiologic analysis of Clostridium difficile. J Clin Microbiol 1996, 34:1153-1157. Representatives of the 10 serogroups, epidemic clusters and random (non)- toxigenic clinical strains were subjected to two RAPD tests and the data were compared with PCR ribotyping results. In addition, several of the groups were re-analysed with PFGE. The conclusion was that PCR ribotyping may be the method of choice for the preliminary genetic screening of C. difficile isolates.
15. Liebisch B, Schwarz S: Evaluation and comparison of molecular techniques for epidemiological typing of Salmonella enterica subsp. enterica serovar dublin. J Clin Microbiol 1996, 34:641-646.
16. Tyler KD, Wang G, Tyler SD, Johnson WM: Factors affecting reliability and reproducibility of amplification based DNA finger- printing of representative bacterial pathogens. J Clin Microbiol 1997, 35:339-346.
17. Power EGM: RAPD typing in microbiology - a technical review. J Hosp Infect 1996, 34:247-265.
18. Cheung VG, Nelson SF: Whole genome amplification using a degenerate oligonucleotide primer allows hundreds of genotypes to be performed on less than one nanogram of genomic DNA. Proc Natl Acad Sci U S A 1996, 93:14676-14679.
19. Calderwood SB, Baker MA, Carroll PA, Michel JL, Arbeit RD, Ausubel FM: Use of cleaved amplified polymorphic sequences to distinguish strains of Staphylococcus epidermidis. J Clin Microbiol 1996, 34:2860-2865. On the basis of seven PCRs in combination with subsequent restriction enzyme-mediated DNA digestion, 128 theoretical combinations of molecular characters can be established. The approach can be easily extrapolated to other species.
20. Van Leeuwen W, Sijmons M, Slujis J, Verbrugh H, Val Belkum A: On the nature and use of randomly amplified DNA from Staphytococcus aureus. J Clin Microbiol 1996, 34:2770-2777.
21. Janssen P, Coopman R, Huys G, Swings J, Bleeker M, Vos P, Zabeau M, Kersters K: Evaluation of the DNA fingerprinting method AFLP as a new tool in bacterial taxonomy. Microbiology 1996, 142:1881- 1893.
22. Schreiber GB, Busch MP, Kleinman SH, Korelitz JJ, and the Retrovirus Epidemiology Donor Study: The risk of transfusion-transmitted viral infections. New Engl J Med 1996, 334:1685-1690.
23. Munro J, Briggs JD, McCruden EAB: Detection of a cluster of hepatitis C infections in a renal transplant unit by analysis of sequence variation of the NS5a gene. J Infect Dis 1996, 174:177- 180.
24. Hardie DR, Kannemeyer J, Stannard LM: DNA single strand conformation polymorphism identifies five defined strains of hepatitis B virus (HBV) during an outbreak of HBV infection in an oncology unit. J Med Virol 1996, 49:49-54.
25. Nachamkin I, Ung H, Patton CM: Analysis of HL and O serotypes of Campylobacter strains by the flagellin gene typing system. J Clin Microbiol 1996, 34:277-281.
26. 3. Infect Immun 1996, 64:2945-2949.
27. Vandamme P, Vercauteren E, Lammens C, Pensart N, Leven M, Pot B, Leclercq R, Goossens H: Survey of enterococcal susceptibility patterns in Belgium. J Clin Microbiol 1996, 34:2572-2576.
28. Landman D, Quale JM, Oydna E, Willey B, Ditore V, Zaman M, Patel K, Saurina G, Huang W: Comparison of five selective media for identifying fecal carriage of vancomycin-resistant enterococci. J Clin Microbiol 1996, 34:751-752.
29. Barbier N, Saulnier P, Chachaty E, Dumontier S, Andremont A: Random amplified polymorphic DNA typing versus pulsed field gel electrophoresis for epidemiological typing of vancomycin resistant enterococci. J Clin Microbiol 1996, 34:1096-1099.
30. Bodnar UR, Noskin GA, Suriano T, Cooper I, Reisberg BE, Peterson LR: Use of in-house studies of molecular epidemiology and full species identification for controlling spread of vancomycin resistant Enterococcus faecalis isolates. J Clin Microbiol 1996, 34:2129-2132.
31. Biavasco F, Miele A, Vignaroli C, Manso E, Lupidi R: Genotypic characterisation of a nosocomial outbreak of VanA Enterococcus faecalis. Microb Drug Resist 1996, 2:231-237.
32. Van Belkum A, Van den Braak N, Thomassen R, Verbrugh H, Endtz H: Vancomycin resistant enterococci in cats and dogs. Lancet 1996, 348:1038-1039. In 48% of 24 cats and in 16% of 23 dogs, rectal carriage of VRE could be documented. In total, 17% of cats and dogs harboured VanA. E faecium (highly resistant to both vancomycin and teicoplanin), and an overlap in genotypes could be observed among strains derived both from cats and dogs.
33. Aarestrup FM, Ahrens P, Madsen M, Pallesen LV, Poulsen RL, Westh H: Glycopeptide susceptibility among Danish Enterococuccus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the vanA cluster. Antimicrob Agents Chemother 1996, 40:1938-1940.
34. Fuste MC, Pineda MA, Palomar J, Vinas M, Loren JG: Clonality of multidrug resistant nontypeable strains of Haemophilus influenzae. J Clin Microbiol 1996, 34:2760-2765.
35. Leaves NI, Jordens JZ: Analysis of the prevaccine population of nonencapsulate Haemophilus influenzae and identification of a putative epidemic clone. Eur J Clin Microbiol Infect Dis 1996, 15:410-414.
36. Urwin G, Krohn JA, Deaver-Robinson C, Wenger JD, Farley MM, and the H. influenzae study group: Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiologic characteristics in the H. influenzae serotype b vaccine era. Clin Infect Dis 1996, 22:1069-1076.
37. Karlin S, Mrazek J, Campbell AM: Frequent oligonucleotides and peptides of the Haemophilus influenzae genome. Nucl Acids Res 1996, 24:4263-4272.
38. Hood DW, Deadman ME, Jennings MP, Bisercic M, Fleischmann RD, Venter JC, Moxon ER: DNA repeats identify novel virulence genes in Haemophilus influenzae. Proc Natl Acad Sci U S A 1996, 93:11121- 11125. The availability of the whole genome sequence made possible the identification of repetitive DNA moieties consisting of simple, mainly tetrameric sequences. Length variation in these elements seemed to correspond with modulation in bacterial virulence. The functionality of these so-called contingency loci depend on the number of repeats present: virulence modulation takes place by a sort of bacterial replication floppiness with respect to repetitive DNA, induced by slipped strand mispairing. Subsequent selective advantage can guide the way to clonal expansion of a certain genotype. Current studies in our laboratory are establishing the potential usefulness of these repeats as molecular markers for strain tracking.
39. Madoff LC, Michel JL, Gong EW, Kling DE, Kasper DL: Group B streptococci escape host immunity by deletion of tandem repeat elements of the alpha C protein. Proc Natl Acad Sci USA 1996, 93:4131-4136.
40. Gravekamp C, Horensky DS, Michel JL, Madoff LC: Variation in repeat number within the alpha C protein of group B streptococci alters antigenicity and protective epitopes. Infect Immun 1996, 64:3576-3583.
41. Hall LMC, Whiley RA, Duke B, George RC, Efstratiou A: Genetic relatedness within and between serotypes of Streptococcus pneumoniae from the United Kingdom: analysis of multilocus enzyme electrophoresis, pulsed field gel electrophoresis and antimicrobial resistance patterns. J Clin Microbiol 1996, 34:853-859.
42. Ferroni A, Nguyen L, Gehanno P, Boucot I, Berche P: Clonal distribution of penicillin resistant Streptococcus pneumoniae 23 F in France. J Clin Microbiol 1996, 34:2707-2712.
43. Van Belkum A, Sluijter M, De Groot R, Verbrugh HA, Hermans P: Novel BOX repeat PCR assay for high resolution typing of Streptococcus pneumoniae strains. J Clin Microbiol 1996, 34:1176-1179.
44. Philipp WJ, Poulet S, Eiglmeier K, Pascopella L, Balasubramanian V, Heym B, Bergh S, Bloom BR, Jacobs Jr WR, Cole ST: An integrated map of the genome of the tubercle bacillus, Mycobacterium tuberculosis H37Rv, and comparison with Mycobacterium leprae. Proc Natl Acad Sci U S A 1996, 93:3132-3137.
45. Aranaz A, Liebana E, Mateos A, Dominguez L, Vidai D, Domingo M, Gonzolez O, Rodriguez-Ferri EF, Bunschoten AE, Van Embden JDA, Cousins D: Spacer oligonucleotide typing of Mycobacterium bovis strains from cattle and other animals: a tool for studying epidemiology of tuberculosis. J Clin Microbiol 1996, 34:2734-2740. Similar procedures have also been developed for M. tuberculosis. This work is still, however, in progress, although the availability of 37 spacer probes for this species has been announced.
46. Schmidt K, Tummler B, Römling U: Comparative genome mapping of Pseudomonas aeruginosa PAO with P. aeruginosa C, which belongs to a major clone in cystic fibrosis patients and aquatic habitats. J Bacteriol 1996, 178:85-93.
47. Bennekov T, Colding H, Ojeniyi B, Bentzon MW, Hoiby N: Comparison of ribotyping and genome fingerprinting of Pseudomonas aeruginosa isolates from cystic fibrosis patients. J Clin Microbiol 1996, 34:202-204.
48. Hla SW, Hui KP, Tan WC, Ho B: Genome macrorestriction analysis of sequential Pseudomonas aeruginosa isolates from bronchiectasis patients without cystic fibrosis. J Clin Microbiol 1996, 34:575- 578.
49. Govan JRW, Deretic V: Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 1996, 60:539-574.
50. Struelens MJ, Ronveaux O, Jans B, Mertens R, et le Groupement pour le Depistage, l'Etude et la Prevention des Infections Hospitalieres Methicillin-resistant Staphylococcus aureus epidemiology and control in Belgian hospitals, 1991 to 1995. Infect Control Hosp Epidemiol 1996, 17:503-508.
51. Frenay HME, Bunschoten AE, Schouls LM, Van Leeuwen WJ, Vandenbroucke-Grauls CMJE, Verhoef J, Mooi FR: Molecular typing of methicillin resistant Staphylococcus aureus on the basis of protein A gene polymorphisms. Eur J Clin Microbiol Infect Dis 1996, 15:60-64.
52. Van Belkum A, Riewerts Eriksen N, Sijmons M, Van Leeuwen W, Vandenbergh M, Kluytmans J, Espersen F, Verbrugh H: Are variable repeats in the spa gene suitable targets for epidemiological studies of methicillin resistant Staphylococcus aureus strains? Eur J Clin Microbiol Infect Dis 1996, 15:768-769.
53. Smeltzer M, Pratt FL, Gillaspy AF, Young LA: Genomic fingerprinting for epidemiological differentiation of Staphylococcus aureus clinical isolates. J Clin Microbiol 1996, 34:1364-1372.
54. Cuny C, Witte W: Typing of Staphylococcus aureus by PCR for DNA sequences flanked by transposon Tn916 target region and ribosomal binding site. J Clin Microbiol 1996, 34:1502-1505.
55. Jorgensen M, Givney R, Pegler M, Vickery A, Funnell G: Typing multidrug-resistant Staphylococcus aureus: conflicting epidemiological data produced by genotypic and phenotypic methods clarified by phylogenetic analysis. J Clin Microbiol 1996, 34:398-403.
56. Zaidi AKM, Harrell LJ, Rost JR, Relier LB: Assessment of similarity among coagulase negative staphylococci from sequential blood cultures of neonates and children by pulsed field gel electrophoresis. J Infect Dis 1996, 174:1010-1014.
57. Van Belkum A, Kluytmans J, Van Leeuwen W, Goessens W, Ter Averst E, Wielenga J, Verbrugh H: Monitoring persistence of coagulase negative staphylococci in a haematology department using phenotypic and genotypic strategies. Infect Control Hosp Epidemiol 1996, 17:660-667.
58. Fridkin SK, Jarvis WR: Epidemiology of nosocomial fungal infections. Clin Microbiol Rev 1996, 9:499-511. A comprehensive and complete overview of fungal problems in clinical settings. Covers everything from risk factors to control.
59. Pfaller MA: Nosocomial candidiasis: emerging species, reservoirs and modes of transmission. Clin Infect Dis 1996, 22(Suppl 2):S89-94.
60. Leenders A, Van Belkum A, Janssen S, De Marie S, Kluijtmans J, Wielenga J, Lowenberg B, Verbrugh H: Molecular epidemiology of apparent outbreak of invasive aspergillosis in a haematology ward. J Clin Microbiol 1996, 34:345-351.
61. Carter DA, Burt A, Taylor JW, Koenig GL, White TJ: Clinical isolates of Histoplasma capsulatum from Indianopolis, Indiana, have a recombining population structure. J Clin Microbiol 1996, 34:2577-2584. 'Populations of the true human mycopathogens have remained poorly characterised, mostly as a result of the difficulties associated with working with large numbers of hazardous microorganisms. The development of simple, reliable PCR-based techniques like those used in this study, combined with the growing importance of fungal diseases as causes for human morbidity and mortality, provides impetus for further analyses of these microorganisms at the population level. We intend to extend our analyses to clinical and environmental samples of H. capsulatum from different geographical regions in order to further clarify the population structure and substructure of this important mycopathogen'. This study should serve as an example for future studies with other mycopaths. From a technical perspective, the methodology developed should be amenable to multicentred approaches, allowing large-scale in-depth studies for a multitude of fungal species.
62. Rees JC, Allen KD: Holy water - a risk factor for hospital acquired infection. J Hosp Infect 1996, 32:51-55.
63. Ridgeway GL, Tedder RS: Birthing pools and infection control. Lancet 1996, 347:1051-1052.
64. Hermans PWM, Saha SK, Van Leeuwen WJ, Verbrugh HA, Van Belkum A, Goessens WHF: Molecular typing of Salmonella typhi strains from Dhaka (Bangladesh) and development of DNA probes identifying plasmid-encoded multidrug-resistant isolates. J Clin Microbiol 1996, 34:1373-1379.